Ionis Pharmaceuticals

Ionis Pharmaceuticals, Inc.
FormerlyIsis Pharmaceuticals, Inc.
TypePublic
IndustryBiotechnology
Founded1989 (1989)
FounderStanley T. Crooke
HeadquartersCarlsbad, California, U.S.
Key peopleBrett P. Monia (CEO)
Elizabeth L. Hougen (CFO)
Joseph Loscalzo
(chairman of the board)
Productsnusinersen, olezarsen, eplontersen, tofersen, inotersen, volanesorsen
RevenueDecrease US$705.1 million (2024)
Decrease US$453.9 million (2024)
Total assetsIncrease US$3.003 billion (2024)
Total equityIncrease US$588.4 million (2024)
Number of employees
1,069 (2024)
Websiteionispharma.com
Footnotes

Ionis Pharmaceuticals, Inc. is a biotechnology company that specializes in discovering and developing antisense therapy, as well as RNA interference and CRISPR therapeutics. The company was founded in 1989 is based in Carlsbad, California. The company was previously known as Isis Pharmaceuticals until December 2015.